Target intelligence / Profile preview

Natural killer cell recognition system (NKCR)

Target
NKCR
Molecular classification
Receptor, Immune checkpoint, Cell surface protein
01

Overview

Natural Killer (NK) cell recognition via missing-self and stress ligands is a fundamental immunological process used to identify and eliminate compromised cells. The 'missing-self' hypothesis describes how NK cells detect the downregulation of MHC class I molecules—a common evasion tactic by tumors and viruses—which otherwise provide inhibitory signals through receptors like Killer-cell Immunoglobulin-like Receptors (KIRs) (Kärre et al., 1986). Complementing this, 'stress ligands' such as MICA, MICB, and ULBPs are expressed by cells undergoing DNA damage or malignant transformation, binding to the activating receptor NKG2D to trigger NK cell-mediated lysis (Raulet, 2003). This recognition system is a critical target in cancer immunotherapy, where therapeutic strategies aim to either block inhibitory 'checkpoints' (e.g., using Monalizumab to block NKG2A) or enhance the visibility of stress ligands. Therapeutic success depends on overcoming tumor-driven resistance mechanisms, such as the proteolytic shedding of stress ligands which acts as a decoy for NK cells (Groh et al., 2002). Overall, this system balances inhibitory and activating signals to ensure precise immune surveillance while maintaining self-tolerance (Vivier et al., 2012).

Other names
Missing-self recognitionStress-induced ligand recognitionNK cell immunosurveillanceNKG2D-MICA/B axisKIR-HLA axisNK cell activation pathway
02

Mechanism of action

The system is targeted by blocking inhibitory receptors such as KIR and NKG2A to prevent 'missing-self' evasion or by engaging activating receptors like NKG2D to recognize stress-induced ligands on target cells.

03

Biological functions

Immune responseCytotoxicityApoptosisCell deathImmunosurveillance
04

Disease associations

CancerInfectionAutoimmune disease
05

Safety considerations

Autoimmunity due to loss of self-toleranceCytokine release syndromeOff-target toxicity against healthy tissues expressing stress ligandsResistance via ligand shedding
06

Interacting drugs

Lirilumab

2 more in the full profile.

07

Biomarkers

HLA class I expressionMICA/B surface expressionULBP1-6 expressionNKG2D expression levelsKIR genotypeSoluble MICA levels

Beyond the preview

Go deeper on Natural killer cell recognition system (NKCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer cell recognition system (NKCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call